Publications by authors named "Guillermo Deben"

Claim this Profile
A
A randomized phase II study comparing consolidation with a single dose of Y ibritumomab tiuxetan maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results.
Armando López-Guillermo, Miguel Ángel Canales, Ivan Dlouhy, Santiago Mercadal, Javier Briones, Guillermo Deben

Leuk Lymphoma· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
Julia González-Rincón, José A Garcia-Vela, Sagrario Gómez, Belén Fernández-Cuevas, Sara Nova-Gurumeta, Guillermo Deben

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients.
Jordi Ribera, Isabel Granada, Mireia Morgades, Susana Vives, Eulàlia Genescà

Br J Haematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
Antonio M Almeida, Thomas Prebet, Raphael Itzykson, Fernando Ramos, Haifa Al-Ali, Guillermo Deben

Int J Mol Sci· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.
Francisco Javier Peñalver, Julio Delgado, Javier Loscertales, Jose Luis Sastre, Asunción Peña

Eur J Haematol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program.
Valentín García-Gutiérrez, Alejandra Martinez-Trillos, Jose Luis Lopez Lorenzo, Guiomar Bautista, Maria Luisa Martin Mateos, Guillermo Deben

Am J Hematol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse interstitial lung disease as a first manifestation of Waldenström's macroglobulinemia: case report and review of the literature.
Angélica Consuegra, Pedro J Marcos, Rubén Vázquez, Jorge Pombo, Guillermo Debén

Arch Bronconeumol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients.
José Luis Piñana, Pau Montesinos, Rodrigo Martino, Lourdes Vazquez, Montserrat Rovira

Ann Hematol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
Martin S Tallman, Haesook T Kim, Pau Montesinos, Frederick R Appelbaum, Javier de la Serna, Guillermo Deben

Blood· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
Javier de la Rubia, Federico Moscardó, María J Gómez, Ramón Guardia, Pilar Rodríguez

Transfus Apher Sci· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
Juan-Manuel Sancho, Alberto Orfao, Sandra Quijano, Olga García, Carlos Panizo, Guillermo Deben

Eur J Haematol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy.
Pau Montesinos, José D González, José González, Chelo Rayón, Elena de Lisa

J Clin Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.
Pau Montesinos, Joaquín Díaz-Mediavilla, Guillermo Debén, Virginia Prates, Mar Tormo

Haematologica· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma.
Jose A Garcia-Marco, Carlos Panizo, Eva Sanchez Garcia, Guillermo Deben, Alberto Alvarez-Larran

Cancer· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
Javier de la Rubia, Pau Montesinos, Rodrigo Martino, Isidro Jarque, Montserrat Rovira

Biol Blood Marrow Transplant· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.
Sandra Quijano, Antonio López, Juan Manuel Sancho, Carlos Panizo, Guillermo Debén

J Clin Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
Pau Montesinos, Juan M Bergua, Edo Vellenga, Chelo Rayón, Ricardo Parody

Blood· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
Alejandro Martín, Eulogio Conde, Montserrat Arnan, Miguel A Canales, Guillermo Deben

Haematologica· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.
Juan-Manuel Sancho, Mireia Morgades, Reyes Arranz, Pascual Fernández-Abellán, Guillermo Deben

Med Clin (Barc)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain.
Juan-Manuel Sancho, Mireia Morgades, Natalia Alonso, Guillermo Deben, Alberto Fernández de Sevilla

Med Clin (Barc)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
Javier de la Serna, Pau Montesinos, Edo Vellenga, Chelo Rayón, Ricardo Parody

Blood· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis.
Juan-Manuel Sancho, Guillermo Deben, Anne Parker, José-Luis Piñana, Simon Bolam

Int J Hematol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Juan-Manuel Sancho, Josep-Maria Ribera, Blanca Xicoy, Mireia Morgades, Albert Oriol

Eur J Haematol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
Jose-Maria Ribera, Juan-José Ortega, Albert Oriol, Pilar Bastida, Carlota Calvo, Guillermo Deben

J Clin Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Juan-Manuel Sancho, Josep-Maria Ribera, Albert Oriol, Jesus-Maria Hernandez-Rivas, Concepcion Rivas, Guillermo Deben

Cancer· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis